US20150018307A1 - Deodorant compositions - Google Patents
Deodorant compositions Download PDFInfo
- Publication number
- US20150018307A1 US20150018307A1 US14/329,297 US201414329297A US2015018307A1 US 20150018307 A1 US20150018307 A1 US 20150018307A1 US 201414329297 A US201414329297 A US 201414329297A US 2015018307 A1 US2015018307 A1 US 2015018307A1
- Authority
- US
- United States
- Prior art keywords
- composition
- cyclodextrin
- fixative
- preservative
- solvent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- AZXQKTIARSADPY-FWAMEDGLSA-N CCC1O[C@H]2O[C@@H]3C(CC)O[C@@H](O[C@@H]4C(CC)O[C@H](O[C@@H]5C(CC)O[C@H](O[C@@H]6C(CC)O[C@@H](O[C@@H]7C(CC)O[C@@H](O[C@H]1[C@H](C)C2C)C(C)[C@H]7C)C(C)[C@H]6C)C(C)[C@H]5C)C(C)[C@H]4C)C(C)[C@H]3C Chemical compound CCC1O[C@H]2O[C@@H]3C(CC)O[C@@H](O[C@@H]4C(CC)O[C@H](O[C@@H]5C(CC)O[C@H](O[C@@H]6C(CC)O[C@@H](O[C@@H]7C(CC)O[C@@H](O[C@H]1[C@H](C)C2C)C(C)[C@H]7C)C(C)[C@H]6C)C(C)[C@H]5C)C(C)[C@H]4C)C(C)[C@H]3C AZXQKTIARSADPY-FWAMEDGLSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/738—Cyclodextrins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/731—Cellulose; Quaternized cellulose derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q15/00—Anti-perspirants or body deodorants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/594—Mixtures of polymers
Definitions
- Vaginal odor is a common problem for women around the world. Many attribute the unpleasant odor to lack of cleanliness. In actuality, the odor is caused by an imbalance in the bacteria within the vagina. Both “good” and “bad” bacteria naturally exist in the vaginal area. However, when the natural ratio of good to bad bacteria becomes imbalanced the result is an unpleasant odor. Vaginal odor can have a significant impact on the lives of those who suffer from it. The sometimes intense odor can adversely impact quality of life by causing those afflicted to shy away from both social and intimate contact. This can significantly affect the ability to construct and maintain healthy relationships.
- the invention provides a deodorant composition comprising ⁇ -cyclodextrin, a fixative, a preservative, and a solvent.
- the invention provides a deodorant composition
- a deodorant composition comprising ⁇ -cyclodextrin, hydroxyethylcellulose, phenoxyethanol, methylparaben, propylene glycol, polysorbate 20 and water.
- the invention provides a method of making a deodorant composition, comprising mixing ingredients comprising ⁇ -cyclodextrin, a fixative, a preservative, and a solvent.
- the invention provides deodorant compositions produced by a method comprising mixing ingredients comprising ⁇ -cyclodextrin, a fixative, a preservative, and a solvent.
- the invention provides a method of deodorizing skin, comprising applying a composition comprising ⁇ -cyclodextrin, a fixative, a preservative, and an emollient.
- the present invention makes use of the discovery that ⁇ -cyclodextrin provides for improved deodorant compositions. Without being bound to any particular theory, it is believed that the ⁇ -cyclodextrin forms inclusion complexes with the chemicals responsible for malodor. Such volatile molecules are thereby trapped in the central cavity of the cyclodextrins, preventing their release in the atmosphere and the resulting malodor.
- the deodorant composition of the invention includes a cyclodextrin.
- a “cyclodextrin” is defined as a compound of Formula 1:
- ⁇ -cyclodextrin where n is equal to 2, is used in the compositions. Without being bound to any particular theory, it appears that the size of the central cavity of ⁇ -cyclodextrin is optimal for forming inclusion complexes with chemicals which cause malodor.
- the R′ and R′′ groups may independently be H, an alkyl and/or an ether group, such as —CH 3 , —CH 2 CH 3 , —CH 2 OCH 3 , —CH 2 OCH 2 CH 3 and —CH 2 CH 2 OCH 3 .
- Preferred cyclodextrins include those where all R′ and R′′ groups are hydrogen atoms, or “natural cyclodextrins.”
- the deodorant composition preferably includes 0.01% (w/w) to 5% (w/w) of the cyclodextrin. More preferably, the composition comprises 0.05% (w/w) to 0.2% (w/w) of the cyclodextrin. Most preferably, the composition comprises 0.1% (w/w) to 0.2% (w/w) of the cyclodextrin. ⁇ -cyclodextrin present in amounts greater than 0.2% may not be stable with respect to precipitation.
- the term “(w/w)” is defined as the ratio of the weight of a component to the weight of the composition containing the component. Unless otherwise noted, all quantities are expressed in (w/w) percentages.
- the composition may be in the form of a lotion, fluid, cream, gel stick, powder or spray.
- the composition is in the form of a solution having a surface tension of less than 70 dyn/cm, more preferably less than 40 dyn/cm, for ease of use as a spray.
- the composition is preferably supplied in a spray bottle.
- compositions When the composition is in the form of a solution, aqueous solutions are preferred. Mixtures of water with water-miscible solvents, for instance alcohols such as methanol, ethanol, and propanol, are also acceptable.
- a fragrance may be added to the composition in order to give it a pleasant odor.
- the quantity of fragrance is preferably 0.01% to 1%, more preferably 0.025% to 0.075%, most preferably 0.04% to 0.06%.
- a fixative is also present in order to aid in maintaining the fragrance on the skin. Without being bound to any particular theory, it appears that the fixative forms a film on the skin and that the fragrance is released from the film slowly over time.
- Example fixatives include polyethylene glycol, polyacrilic acid, vegetable gum, hydroxymethylcellulose, hydroxyethylcellulose, and hydroxypropylcellulose. Hydroxyethylcellulose is a preferred fixative.
- the amount of fixative is ideally sufficient to slow down fragrance release, but not so high as to cause the formation of a tacky, translucent or opaque solution.
- the composition includes 1% to 6% of fixative, more preferably 2% to 5%, most preferably 3.5% to 4.5%.
- a salt may be added to the composition. Without being bound to any particular theory, it appears that the salt improves the solubility of the fixative, yielding a homogeneous, clear solution.
- Preferred salt cations include Na + and K + .
- Preferred salt anions include strong acid counter-ions such as Cl ⁇ .
- the amount of salt in the composition is preferably 0.001% to 0.1%, more preferably 0.005% to 0.05%, most preferably 0.01% to 0.03%.
- Preservatives preferably chosen from those that do not fit in the central cavity of the ⁇ -cyclodextrin, may be added to the composition.
- Example preservatives include the parabens, such as methylparaben, ethylparaben, propylparaben, butylparaben, and their salts.
- Other preservatives include phenoxyethanol, methylisothiazoline, benzoic acid, 1,3-bis(hydroxymethyl)-5,5-dimethylimidazolidine-2,4-dione (also known as DMDM hydantoin), and sodium hydroxymethyl glycinate.
- Preferred preservatives include commercially available preservative blends, for example the NEOLONETM family of preservatives (available from Rohm & Haas, Philadelphia, Pa.), such as NEOLONETM MXP (a mixture including phenoxyethanol, methylparaben, propylparaben and methylisothiazolone).
- Other preservatives include Bronopol (2-bromo-2-nitropropane-1,3-diol) and Optiphen MIT Plus (a mixture of methylisothiazolinone, phenethyl alcohol and PPG-2-methyl ether), a combination of which provides preservation against the broadest group of microorganisms, when combined with EDTA at a pH of 5.1.
- the composition preferably includes 0.01% to 1% of a preservative.
- the amount of preservative is more preferably 0.1% to 0.9%, most preferably 0.1% to 0.5%.
- Surfactants may be added to the composition to increase the solubility of the cyclodextrin and/or other components. Surfactants that are routinely used in skin care products are preferred.
- Example surfactants include polysorbates, for example polysorbate 20 (polyoxyethylene (20) sorbitan monolaurate), polysorbate 40 (polyoxyethylene (20) sorbitan monopalmitate), polysorbate 60 (polyoxyethylene (20) sorbitan monostearate), and polysorbate 80 (polyoxyethylene (20) sorbitan monooleate).
- Fatty acids, their ethoxylated derivatives, and their salts, for instance cocoamphocarboxyglycinate disodium and cocoamidopropyl oxide, provide additional classes of surfactants for the composition.
- the composition preferably includes 0.01% to 3% of a surfactant.
- the amount of surfactant is more preferably 0.1% to 2%, most preferably 0.5% to 1.5%.
- the pH of the composition is preferably 4.5 to 5.5. More preferably, the pH is 4.7 to 5.3, most preferably 4.9 to 5.1.
- a pH adjusting agent for example an acid, base, or buffer, may be added to the composition to adjust the pH to desired values.
- Example pH adjusting agents include organic acids, mineral acids, ammonia, amines, and alkali metal and alkaline earth metal salts of weak acid anions such as carbonate, acetate, carbamate, citrate, glutamate, phosphate, polyphosphate, silicate, and borate.
- Organic acids and particularly carboxylic acids, are preferred pH adjusting agents. More preferred organic acids include those usually found in skin care products, notably ⁇ -hydroxy acids such as citric acid, lactic acid, glycolic acid, and mandelic acid.
- Chelating agents may also be part of the composition, for example to prevent oxidation reactions catalyzed by metal ions such as Mg 2+ and Ca 2+ .
- Example chelating agents include ethylenediaminetetraacetic acid (EDTA), ethylene glycol tetraacetic acid (EGTA), N,N′-ethylenediaminediacetic acid (H 2 EDDA), 1,2-diaminocyclohexane-N,N,N′,N′-tetraacetic acid (H 4 CyDTA), 2,3-dimercapto-1-propanesulfonic acid (DMPS), dimercaptosuccinic acid (DMSA), diethylene triamine pentaacetic acid (DTPA), and crown ethers, as well as salts and complexes thereof.
- EDTA ethylenediaminetetraacetic acid
- EGTA ethylene glycol tetraacetic acid
- H 2 EDDA N,N′-ethylenediaminediacetic
- the composition preferably includes 0.005% to 1% of a chelating agent.
- the amount of chelating agent is more preferably 0.01% to 0.5%, most preferably 0.03% to 0.08%. 0.05% EDTA is especially preferred.
- Moisturizers such as those commonly used in skin care products, may also be present in the composition.
- Example moisturizers include hyaluronic acid and its salts, sodium pyrrolidone carbonic acid (sodium PCA), and PEG-75 lanolin, (ethoxylated lanolin with a mean chain length of 75 ethylene oxide units).
- hyaluronic acid or one of its salts When hyaluronic acid or one of its salts is added to the composition, it is preferably in amounts ranging from 0.05% to 2%, more preferably 0.1% to 1%, most preferably 0.15% to 0.3%. If sodium PCA is added, preferred amounts are from 0.1% to 2%, more preferably 0.5% to 1.5%, most preferably 0.8% to 1.2%. In the case PEG-75 lanolin is added, preferred amounts are 0.1% to 2%, more preferably 0.2% to 0.6%, most preferably 0.3% to 0.5%.
- the composition may also contain emollients.
- Emollients routinely used in skin care are preferred, for example vegetable oils such as coconut oil, palm kernel oil, nut oil, mineral oils such as petroleum jelly, waxes such as carnauba wax and paraffin wax, and synthetic emollients such as silicon oil and propylene glycol. Propylene glycol is particularly preferred.
- the composition preferably includes 0.01% to 10% of an emollient.
- the amount of emollient is more preferably 0.1% to 2%, most preferably 0.2% to 0.8%.
- Instructions may be optionally provided with the deodorant compositions of the invention. Instructions may include directions regarding how to apply the compositions to the human body.
- the instructions may be present in a variety of forms, including one or more printed sheets, printing on the outside or inside the exterior package, writing incorporated on one or more of the containers enclosed in the exterior package, a CD-ROM, a DVD-ROM, a uniform resource locator (URL) for a website, and the like.
- the optional exterior package may be sized and configured to contain one or more other components of the composition.
- An exterior package may be a cup, a bottle, a vial, a tube, or the like, which may be formed in part or in whole from plastic, glass, paper, STYROFOAM®, and the like.
- a spray bottle is a preferred packaging for the composition.
- the optional exterior package may include one or more supporting structures, such as walls, wells, movable or removable trays, etc., so as to segregate the various components of the composition.
- Supporting structures may be formed in part or in whole from plastic, glass, paper, STYROFOAM®, and the like.
- liquid deodorant composition comprising ⁇ -cyclodextrin
- the ingredients of a liquid deodorant composition were mixed in a vessel in the quantities shown below in the table.
- the composition is preferably applied to the body by means of a sprayer.
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Cosmetics (AREA)
Abstract
A deodorant composition contains β-cyclodextrin, a fixative, a preservative, and a solvent.
Description
- This application claims priority to provisional application no. 61/389,132 entitled “Deodorant Compositions” filed 1 Oct. 2010, attorney docket no. FLE01-072-PRO, the entire contents of which are hereby incorporated by reference, except where inconsistent with the present application.
- Vaginal odor is a common problem for women around the world. Many attribute the unpleasant odor to lack of cleanliness. In actuality, the odor is caused by an imbalance in the bacteria within the vagina. Both “good” and “bad” bacteria naturally exist in the vaginal area. However, when the natural ratio of good to bad bacteria becomes imbalanced the result is an unpleasant odor. Vaginal odor can have a significant impact on the lives of those who suffer from it. The sometimes intense odor can adversely impact quality of life by causing those afflicted to shy away from both social and intimate contact. This can significantly affect the ability to construct and maintain healthy relationships.
- In a first aspect, the invention provides a deodorant composition comprising β-cyclodextrin, a fixative, a preservative, and a solvent.
- In a second aspect, the invention provides a deodorant composition comprising β-cyclodextrin, hydroxyethylcellulose, phenoxyethanol, methylparaben, propylene glycol, polysorbate 20 and water.
- In a third aspect, the invention provides a method of making a deodorant composition, comprising mixing ingredients comprising β-cyclodextrin, a fixative, a preservative, and a solvent.
- In a fourth aspect, the invention provides deodorant compositions produced by a method comprising mixing ingredients comprising β-cyclodextrin, a fixative, a preservative, and a solvent.
- In a fifth aspect, the invention provides a method of deodorizing skin, comprising applying a composition comprising β-cyclodextrin, a fixative, a preservative, and an emollient.
- The present invention makes use of the discovery that β-cyclodextrin provides for improved deodorant compositions. Without being bound to any particular theory, it is believed that the β-cyclodextrin forms inclusion complexes with the chemicals responsible for malodor. Such volatile molecules are thereby trapped in the central cavity of the cyclodextrins, preventing their release in the atmosphere and the resulting malodor.
- The deodorant composition of the invention includes a cyclodextrin. A “cyclodextrin” is defined as a compound of Formula 1:
- β-cyclodextrin, where n is equal to 2, is used in the compositions. Without being bound to any particular theory, it appears that the size of the central cavity of β-cyclodextrin is optimal for forming inclusion complexes with chemicals which cause malodor.
- The R′ and R″ groups may independently be H, an alkyl and/or an ether group, such as —CH3, —CH2CH3, —CH2OCH3, —CH2OCH2CH3 and —CH2CH2OCH3. Preferred cyclodextrins include those where all R′ and R″ groups are hydrogen atoms, or “natural cyclodextrins.”
- The deodorant composition preferably includes 0.01% (w/w) to 5% (w/w) of the cyclodextrin. More preferably, the composition comprises 0.05% (w/w) to 0.2% (w/w) of the cyclodextrin. Most preferably, the composition comprises 0.1% (w/w) to 0.2% (w/w) of the cyclodextrin. β-cyclodextrin present in amounts greater than 0.2% may not be stable with respect to precipitation. The term “(w/w)” is defined as the ratio of the weight of a component to the weight of the composition containing the component. Unless otherwise noted, all quantities are expressed in (w/w) percentages.
- The composition may be in the form of a lotion, fluid, cream, gel stick, powder or spray. Preferably, the composition is in the form of a solution having a surface tension of less than 70 dyn/cm, more preferably less than 40 dyn/cm, for ease of use as a spray. The composition is preferably supplied in a spray bottle.
- When the composition is in the form of a solution, aqueous solutions are preferred. Mixtures of water with water-miscible solvents, for instance alcohols such as methanol, ethanol, and propanol, are also acceptable.
- A fragrance may be added to the composition in order to give it a pleasant odor. The quantity of fragrance is preferably 0.01% to 1%, more preferably 0.025% to 0.075%, most preferably 0.04% to 0.06%.
- A fixative is also present in order to aid in maintaining the fragrance on the skin. Without being bound to any particular theory, it appears that the fixative forms a film on the skin and that the fragrance is released from the film slowly over time. Example fixatives include polyethylene glycol, polyacrilic acid, vegetable gum, hydroxymethylcellulose, hydroxyethylcellulose, and hydroxypropylcellulose. Hydroxyethylcellulose is a preferred fixative.
- The amount of fixative is ideally sufficient to slow down fragrance release, but not so high as to cause the formation of a tacky, translucent or opaque solution. Preferably, the composition includes 1% to 6% of fixative, more preferably 2% to 5%, most preferably 3.5% to 4.5%.
- Small quantities of a salt may be added to the composition. Without being bound to any particular theory, it appears that the salt improves the solubility of the fixative, yielding a homogeneous, clear solution. Preferred salt cations include Na+ and K+. Preferred salt anions include strong acid counter-ions such as Cl−. The amount of salt in the composition is preferably 0.001% to 0.1%, more preferably 0.005% to 0.05%, most preferably 0.01% to 0.03%.
- Preservatives, preferably chosen from those that do not fit in the central cavity of the β-cyclodextrin, may be added to the composition. Example preservatives include the parabens, such as methylparaben, ethylparaben, propylparaben, butylparaben, and their salts. Other preservatives include phenoxyethanol, methylisothiazoline, benzoic acid, 1,3-bis(hydroxymethyl)-5,5-dimethylimidazolidine-2,4-dione (also known as DMDM hydantoin), and sodium hydroxymethyl glycinate. Preferred preservatives include commercially available preservative blends, for example the NEOLONE™ family of preservatives (available from Rohm & Haas, Philadelphia, Pa.), such as NEOLONE™ MXP (a mixture including phenoxyethanol, methylparaben, propylparaben and methylisothiazolone). Other preservatives include Bronopol (2-bromo-2-nitropropane-1,3-diol) and Optiphen MIT Plus (a mixture of methylisothiazolinone, phenethyl alcohol and PPG-2-methyl ether), a combination of which provides preservation against the broadest group of microorganisms, when combined with EDTA at a pH of 5.1.
- The composition preferably includes 0.01% to 1% of a preservative. The amount of preservative is more preferably 0.1% to 0.9%, most preferably 0.1% to 0.5%.
- Surfactants may be added to the composition to increase the solubility of the cyclodextrin and/or other components. Surfactants that are routinely used in skin care products are preferred. Example surfactants include polysorbates, for example polysorbate 20 (polyoxyethylene (20) sorbitan monolaurate), polysorbate 40 (polyoxyethylene (20) sorbitan monopalmitate), polysorbate 60 (polyoxyethylene (20) sorbitan monostearate), and polysorbate 80 (polyoxyethylene (20) sorbitan monooleate). Fatty acids, their ethoxylated derivatives, and their salts, for instance cocoamphocarboxyglycinate disodium and cocoamidopropyl oxide, provide additional classes of surfactants for the composition.
- The composition preferably includes 0.01% to 3% of a surfactant. The amount of surfactant is more preferably 0.1% to 2%, most preferably 0.5% to 1.5%.
- The pH of the composition is preferably 4.5 to 5.5. More preferably, the pH is 4.7 to 5.3, most preferably 4.9 to 5.1. A pH adjusting agent, for example an acid, base, or buffer, may be added to the composition to adjust the pH to desired values. Example pH adjusting agents include organic acids, mineral acids, ammonia, amines, and alkali metal and alkaline earth metal salts of weak acid anions such as carbonate, acetate, carbamate, citrate, glutamate, phosphate, polyphosphate, silicate, and borate.
- Organic acids, and particularly carboxylic acids, are preferred pH adjusting agents. More preferred organic acids include those usually found in skin care products, notably α-hydroxy acids such as citric acid, lactic acid, glycolic acid, and mandelic acid.
- Chelating agents may also be part of the composition, for example to prevent oxidation reactions catalyzed by metal ions such as Mg2+ and Ca2+. Example chelating agents include ethylenediaminetetraacetic acid (EDTA), ethylene glycol tetraacetic acid (EGTA), N,N′-ethylenediaminediacetic acid (H2EDDA), 1,2-diaminocyclohexane-N,N,N′,N′-tetraacetic acid (H4CyDTA), 2,3-dimercapto-1-propanesulfonic acid (DMPS), dimercaptosuccinic acid (DMSA), diethylene triamine pentaacetic acid (DTPA), and crown ethers, as well as salts and complexes thereof.
- The composition preferably includes 0.005% to 1% of a chelating agent. The amount of chelating agent is more preferably 0.01% to 0.5%, most preferably 0.03% to 0.08%. 0.05% EDTA is especially preferred.
- Moisturizers, such as those commonly used in skin care products, may also be present in the composition. Example moisturizers include hyaluronic acid and its salts, sodium pyrrolidone carbonic acid (sodium PCA), and PEG-75 lanolin, (ethoxylated lanolin with a mean chain length of 75 ethylene oxide units).
- When hyaluronic acid or one of its salts is added to the composition, it is preferably in amounts ranging from 0.05% to 2%, more preferably 0.1% to 1%, most preferably 0.15% to 0.3%. If sodium PCA is added, preferred amounts are from 0.1% to 2%, more preferably 0.5% to 1.5%, most preferably 0.8% to 1.2%. In the case PEG-75 lanolin is added, preferred amounts are 0.1% to 2%, more preferably 0.2% to 0.6%, most preferably 0.3% to 0.5%.
- The composition may also contain emollients. Emollients routinely used in skin care are preferred, for example vegetable oils such as coconut oil, palm kernel oil, nut oil, mineral oils such as petroleum jelly, waxes such as carnauba wax and paraffin wax, and synthetic emollients such as silicon oil and propylene glycol. Propylene glycol is particularly preferred. The composition preferably includes 0.01% to 10% of an emollient. The amount of emollient is more preferably 0.1% to 2%, most preferably 0.2% to 0.8%.
- Instructions may be optionally provided with the deodorant compositions of the invention. Instructions may include directions regarding how to apply the compositions to the human body. The instructions may be present in a variety of forms, including one or more printed sheets, printing on the outside or inside the exterior package, writing incorporated on one or more of the containers enclosed in the exterior package, a CD-ROM, a DVD-ROM, a uniform resource locator (URL) for a website, and the like.
- The optional exterior package may be sized and configured to contain one or more other components of the composition. An exterior package may be a cup, a bottle, a vial, a tube, or the like, which may be formed in part or in whole from plastic, glass, paper, STYROFOAM®, and the like. A spray bottle is a preferred packaging for the composition.
- The optional exterior package may include one or more supporting structures, such as walls, wells, movable or removable trays, etc., so as to segregate the various components of the composition. Supporting structures may be formed in part or in whole from plastic, glass, paper, STYROFOAM®, and the like.
- The ingredients of a liquid deodorant composition comprising β-cyclodextrin were mixed in a vessel in the quantities shown below in the table. The composition is preferably applied to the body by means of a sprayer.
-
Ingredient Percentage (w/w) Purified water 91.733 Propylene glycol 0.5 Hydroxyethylcellulose 3.75 Polysorbate 20 1 Sodium hyaluronate 0.25 Sodium pyrrolidone carbonic acid 1 PEG-75 lanolin 0.4 Cococamphocarboxyglycinate 0.132 β-cyclodextrin 0.15 Cocoamidopropyl oxide 0.113 Bronopol 0.075-0.1 Optiphen MIT Plus 0.075-0.15 Fragrance 0.05 EDTA 0.05 Sodium chloride 0.005 Citric acid 0.017 - Three preservative levels studied passed a seven (7) day screening test. All three levels were equally effective, with the exception of 0.1% Bronopol with 0.075% Optiphen MIT Plus, which showed a lower efficacy (two log) against the A. niger mold. The table below shows the Log reduction in the microorganism specified after 7 days for the three preservative levels studied.
-
0.1% 0.075% 0.075% Bronopol/0.075% Bronopol/0.175% Bronopol/0.15% Optiphen MIT Optiphen MIT Optiphen MIT Plus Plus Plus E. coli 6 6 6 P. aeruginosa 6 6 6 S. aureus 6 6 6 C. albicans 6 6 6 A. niger 5 7 7 Pool 6 6 6 - While various embodiments of the invention have been described, it will be apparent to those of ordinary skill in the art that other embodiments and implementations are possible within the scope of the invention. Accordingly, the invention is not to be restricted except in light of the attached claims and their equivalents.
Claims (21)
1. A deodorant composition, comprising:
β-cyclodextrin,
a fixative,
a preservative, and
a solvent.
2. The composition of claim 1 , further comprising a fragrance.
3. The composition of claim 1 , wherein the composition comprises 0.01% to 5% of the β-cyclodextrin.
4. The composition of claim 1 , wherein the composition comprises 0.05% to 0.2% of the β-cyclodextrin.
5. The composition of claim 1 , wherein the composition comprises 0.1% to 0.2% of the β-cyclodextrin.
6. The composition of claim 1 , wherein the fixative is selected from the group consisting of polyethylene glycol, polyacrilic acid, vegetable gum, hydroxymethylcellulose, hydroxyethylcellulose, hydroxypropylcellulose, and mixtures thereof.
7. The composition of claim 1 , wherein the fixative is hydroxyethylcellulose.
8. The composition of claim 1 , wherein the composition comprises 1% to 6% of the fixative.
9. The composition of claim 1 , wherein the composition comprises 2% to 5% of the fixative.
10. The composition of claim 1 , wherein the composition comprises 3.5% to 4.5% of the fixative.
11. The composition of claim 1 , wherein the preservative is selected from the group consisting of parabens, salts of parabens, phenoxyethanol, methylisothiazoline, benzoic acid, 1,3-bis(hydroxymethyl)-5,5-dimethylimidazolidine-2,4-dione, sodium hydroxymethyl glycinate, 2-bromo-2-nitropropane-1,3-diol, methylisothiazolinone, phenethyl alcohol, PPG-2-methyl ether, and mixtures thereof.
12. The composition of claim 1 , wherein the composition comprises 0.01% to 1% of the preservative.
13. The composition of claim 1 , wherein the composition comprises 0.1% to 0.9% of the preservative.
14. The composition of claim 1 , wherein the composition comprises 0.1% to 0.5% of the preservative.
15. The composition of claim 1 , wherein the solvent comprises a liquid selected from the group consisting of water, an alcohol, and mixtures thereof.
16. The composition of claim 1 , wherein the solvent comprises water.
17-43. (canceled)
44. A deodorant composition comprising:
β-cyclodextrin,
hydroxyethylcellulose,
phenoxyethanol,
methylparaben,
propylene glycol,
polysorbate 20, and
water.
45. A method of making a deodorant composition, comprising mixing ingredients comprising:
β-cyclodextrin,
a fixative,
a preservative, and
a solvent.
46. A deodorant composition produced by a method comprising mixing ingredients comprising:
β-cyclodextrin,
a fixative,
a preservative, and
a solvent.
47. A method of deodorizing skin, comprising spraying onto skin a composition comprising:
β-cyclodextrin,
a fixative,
a preservative, and
an emollient.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US14/329,297 US20150018307A1 (en) | 2010-10-01 | 2014-07-11 | Deodorant compositions |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US38913210P | 2010-10-01 | 2010-10-01 | |
US13/240,416 US8802653B2 (en) | 2010-10-01 | 2011-09-22 | Deodorant compositions |
US14/329,297 US20150018307A1 (en) | 2010-10-01 | 2014-07-11 | Deodorant compositions |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US13/240,416 Division US8802653B2 (en) | 2010-10-01 | 2011-09-22 | Deodorant compositions |
Publications (1)
Publication Number | Publication Date |
---|---|
US20150018307A1 true US20150018307A1 (en) | 2015-01-15 |
Family
ID=45890330
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US13/240,416 Expired - Fee Related US8802653B2 (en) | 2010-10-01 | 2011-09-22 | Deodorant compositions |
US14/329,297 Abandoned US20150018307A1 (en) | 2010-10-01 | 2014-07-11 | Deodorant compositions |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US13/240,416 Expired - Fee Related US8802653B2 (en) | 2010-10-01 | 2011-09-22 | Deodorant compositions |
Country Status (1)
Country | Link |
---|---|
US (2) | US8802653B2 (en) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8685380B2 (en) | 2010-10-25 | 2014-04-01 | C.B. Fleet Company, Inc. | Deodorant spray |
PL2816996T3 (en) * | 2012-02-24 | 2017-04-28 | Bausch & Lomb Incorporated | Ophthalmic compositions with alkoxylated natural waxes |
ITTO20120554A1 (en) * | 2012-06-22 | 2012-09-21 | Martini Francesco De | COMPOSITION FOR HYDRATION AND PURIFICATION OF THE SKIN. |
FR3000080B1 (en) * | 2012-12-20 | 2015-01-30 | Oreal | WATER INSOLUBLE CYCLODEXTRIN POLYCONDENSATE; USES AS CAPTURE AGENT |
AR105019A1 (en) * | 2015-06-25 | 2017-08-30 | Acraf | DEODORING COMPOSITION THAT INCLUDES OF A CYCLODEXTRINE MIXTURE a, b AND g |
CN111012720A (en) * | 2019-12-21 | 2020-04-17 | 中山市川林生物科技有限公司 | Antiperspirant deodorant body lotion and preparation method thereof |
CN113455506A (en) * | 2021-06-29 | 2021-10-01 | 无锡宏霸医疗科技有限公司 | Water-phase deodorizing agent suitable for daily chemical products and preparation method thereof |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2418338B2 (en) | 1974-04-16 | 1978-09-28 | Henkel Kgaa, 4000 Duesseldorf | Use of esters of citric acid and / or acetylcitric acid in anhydrous cosmetic preparations |
US4675177A (en) | 1980-10-09 | 1987-06-23 | American Cyanamid Company | Antiperspirant compositions |
US4606912A (en) | 1981-07-22 | 1986-08-19 | Caries Research Group Of Rochester, Inc. | Method of making a clear, stable aqueous mouthwash solution and the solution made by that method for the enhancement of cells of the oral cavity and the remineralization of teeth |
US4565693A (en) | 1981-11-09 | 1986-01-21 | Colgate-Palmolive Company | Deodorant composition |
GB8925833D0 (en) | 1989-11-15 | 1990-01-04 | Robertet Sa | Derivatives of aromatic benzoates as inhibitors of esterase-producing micro-organisms |
US5643559A (en) | 1991-10-30 | 1997-07-01 | Colgate-Palmolive Company | Deodorant compositions comprising inhibitors of odor-producing axillary bacterial exoenzymes |
DE4343264A1 (en) | 1993-12-17 | 1995-06-22 | Henkel Kgaa | Deodorising preparations |
US5968488A (en) | 1996-10-21 | 1999-10-19 | Henkel Kommanditgesellschaft Auf Aktien | Deodorizing preparations containing cationic biopolymers, aluminum hydrochlorate and esterase inhibitors |
US6277359B1 (en) | 1999-01-29 | 2001-08-21 | Cognis Deutschland Gmbh | Deodorizing formulation |
US7879820B2 (en) * | 2002-04-22 | 2011-02-01 | L'oreal S.A. | Use of a cyclodextrin as pearlescent agent and pearlescent compositions |
DE10232774B4 (en) | 2002-07-18 | 2004-07-15 | Cognis Deutschland Gmbh & Co. Kg | Cosmetic preparations with antibacterial properties |
ES2336570T3 (en) | 2003-10-24 | 2010-04-14 | Cognis France, S.A.S. | VEGETABLE EXTRACT AND ITS PHARMACEUTICAL AND COSMETIC USE. |
FR2879459B1 (en) * | 2004-12-22 | 2007-02-16 | Galderma Res & Dev | COMPOSITION COMPRISING ADAPALENE SOLUBILIZED WITH CYCLODEXTRINS |
DE102006040302A1 (en) | 2006-08-29 | 2008-03-20 | Henkel Kgaa | Antiperspirant and deodorant compositions with improved care properties |
EP1927656A1 (en) | 2006-12-01 | 2008-06-04 | Symrise GmbH & Co. KG | Skin model |
EP2337544A2 (en) | 2007-04-30 | 2011-06-29 | Living Proof, Inc. | Use of matrix metalloproteinase inhibitors in skin care |
US8685380B2 (en) | 2010-10-25 | 2014-04-01 | C.B. Fleet Company, Inc. | Deodorant spray |
-
2011
- 2011-09-22 US US13/240,416 patent/US8802653B2/en not_active Expired - Fee Related
-
2014
- 2014-07-11 US US14/329,297 patent/US20150018307A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US20120083467A1 (en) | 2012-04-05 |
US8802653B2 (en) | 2014-08-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US8802653B2 (en) | Deodorant compositions | |
US8193232B2 (en) | Anti-fungal formulation | |
TW201201856A (en) | Antimicrobial compositions | |
JP2020111603A (en) | Ophthalmic composition for silicone hydrogel contact lens | |
JP4644682B2 (en) | Use of bisamines to enhance the antimicrobial activity of aqueous compositions | |
CN107427006A (en) | Isobide ether derivant with antiseptic activity | |
US11071699B2 (en) | Deodorant composition | |
JP4611201B2 (en) | Disinfectant composition for dilution | |
WO2020167933A1 (en) | Alcohol-free hydrogen peroxide disinfectant compositions and methods of use thereof | |
JP2016041773A (en) | Pharmaceutical compositions with phosphonium antimicrobial agents | |
JPH10127516A (en) | Wiping liquid composition and wet wiping fiber aggregate | |
JP2005171247A (en) | Stabilizer composition based on monoalkyl glycerol ether and aromatic alcohol | |
EP2276453B1 (en) | Solubilizing agent for essential oils and cosmetic formulations containing them | |
JP3969585B2 (en) | Azulene sulfonate sodium preparation | |
US9497962B1 (en) | Hydroalcoholic foaming sanitizer | |
US8415389B2 (en) | Polyphenol-based composition, and methods and systems for its preparation | |
JPH0563446B2 (en) | ||
JP2006117539A (en) | Oily ointment | |
JPH0812571A (en) | Disinfecting liquid for external use | |
JP2024073548A (en) | Liquid preparation containing azole antifungal agent | |
KR20240035499A (en) | Alcohol-based friction-type hand sanitizer composition with improved usability | |
JP2008143845A (en) | Nasal drop composition and nasal drop spraying tool | |
JP2004067620A (en) | Non-water-based aerosol preparation | |
KR20060133228A (en) | Hand wash compositions |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |